GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30208% above fair value
$238.10+5.02 (+2.15%)
Close on Nov 19, 2026Market cap $14.09BP/E –Yield –
Glaukos free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Glaukos's free cash flow for the twelve months ending Sep 30, 2026 was $36.02M. For fiscal 2025 it was -$22.46M. The highest annual figure on record is $19.78M in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.46M | – |
| FY2024 | Dec 31, 2024 | -$67.62M | – |
| FY2023 | Dec 31, 2023 | -$78.01M | – |
| FY2022 | Dec 31, 2022 | -$63.35M | – |
| FY2021 | Dec 31, 2021 | -$23.08M | – |
| FY2020 | Dec 31, 2020 | -$29.92M | – |
| FY2019 | Dec 31, 2019 | -$5.09M | -159.6% |
| FY2018 | Dec 31, 2018 | $8.55M | -56.8% |
| FY2017 | Dec 31, 2017 | $19.78M | +228.0% |
| FY2016 | Dec 31, 2016 | $6.03M | – |
| FY2015 | Dec 31, 2015 | -$3.07M | – |
| FY2014 | Dec 31, 2014 | -$7.98M | – |
| FY2013 | Dec 31, 2013 | -$14.16M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $36.49M | – |
| Q2 FY2026 | Jun 30, 2026 | $12.09M | +108.4% |
| Q1 FY2026 | Mar 31, 2026 | -$16.49M | – |
| Q4 FY2025 | Dec 31, 2025 | $3.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.73M | – |
| Q2 FY2025 | Jun 30, 2025 | $5.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.46M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.04M | – |
| Q2 FY2024 | Jun 30, 2024 | -$20.52M | – |
| Q1 FY2024 | Mar 31, 2024 | -$34.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.88M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.53M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.93M | – |
| Q1 FY2023 | Mar 31, 2023 | -$37.67M | -1288.4% |
| Q4 FY2022 | Dec 31, 2022 | -$12.36M | – |
| Q3 FY2022 | Sep 30, 2022 | -$32.55M | -513.4% |
| Q2 FY2022 | Jun 30, 2022 | -$21.61M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.17M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.98M | -265.2% |
| Q3 FY2021 | Sep 30, 2021 | $7.87M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.97M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.46M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.65M | -388.6% |
| Q1 FY2020 | Mar 31, 2020 | -$13.88M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.39M | -156.4% |
| Q3 FY2019 | Sep 30, 2019 | -$4.00M | -209.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.73M | +54.3% |
| Q1 FY2019 | Mar 31, 2019 | -$443.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $9.55M | -10.0% |
| Q3 FY2018 | Sep 30, 2018 | $3.64M | -21.1% |
| Q2 FY2018 | Jun 30, 2018 | $3.07M | +2.2% |
| Q1 FY2018 | Mar 31, 2018 | -$7.70M | -591.6% |
| Q4 FY2017 | Dec 31, 2017 | $10.60M | +757.9% |
| Q3 FY2017 | Sep 30, 2017 | $4.61M | – |
| Q2 FY2017 | Jun 30, 2017 | $3.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.24M | – |
See a number that looks wrong?